20 articles
New research reveals how chronic inflammation varies by person, paving the way for personalized interventions to combat age-related diseases.
Découvrez comment l'inflammation chronique de bas grade accélère le processus de vieillissement et apprenez des stratégies pour contrer cette menace silencieuse à la longévité.
A comprehensive review reveals how inflammaging—the fusion of aging and inflammation—fuels cardiovascular disease through senescence, mitochondrial dysfunction, and gut dysbiosis.
Maîtrisez l'architecture moléculaire de la dérégulation du complément dans le vieillissement — de la biochimie des protéines régulatrices aux cibles thérapeutiques de pointe — et comprenez comment des interventions de précision peuvent rétablir l'équilibre sans démanteler l'immunité.
New research reveals how low-grade inflammation creates a cycle of liver damage in older adults, pointing to promising therapeutic targets.
Allez au-delà des bases pour explorer comment les voies du complément, les défaillances régulatrices et les cellules sénescentes interagissent pour alimenter l'inflammation chronique qui accélère le vieillissement au niveau moléculaire.
A major cross-population study finds that chronic inflammation linked to aging may reflect industrialized lifestyles, not biology alone.
BioAge's oral NLRP3 inhibitor BGE-102 cut hsCRP by ~85% in weeks, signaling a potential breakthrough in treating chronic inflammation at scale.
Une analyse mécanistique approfondie des interventions anti-inflammaging de pointe — de la pharmacologie sénolytique et du ciblage précis des cytokines aux stratégies de reprogrammation partielle visant à restaurer l'homéostasie immunitaire juvénile.
New therapies targeting inflammation pathways could reduce cardiovascular disease and slow kidney disease progression in CKD patients.
Belgian biotech Coultreon raises $125M to advance an oral SIK3 inhibitor that rebalances inflammation rather than suppressing immunity outright.
New research links chronic low-grade inflammation to faster epigenetic aging, measured across four validated biological clocks.
New research reveals how fat-derived molecules naturally shut down inflammation, offering hope for safer arthritis and heart disease treatments.
BioAge's oral drug BGE-102 dramatically reduced hsCRP and IL-6 in obese participants with elevated inflammation, with a strong safety profile.
Senescent T cells fuel psoriasis, eczema, and rosacea through toxic secretions. New therapies may finally break the cycle.
Mendelian randomization links circulating inflammatory proteins to retinal microvascular changes, heart disease risk, and lifespan — establishing causal direction.
A landmark 2025 review maps the molecular and cellular mechanisms driving immune aging, linking inflammaging to cancer, neurodegeneration, and infection.
Revolutionary framework combines quarterly biomarker testing with AI-powered lifestyle coaching to reduce aging-related inflammation.
New research maps the connection between cellular senescence, chronic inflammation, and cardiovascular disease progression.
Allez au-delà des bases de l'inflammaging pour comprendre comment le vieillissement remodèle les populations de cellules immunitaires, déclenche le SASP et maintient l'organisme dans un état d'inflammation chronique de bas grade au niveau moléculaire.
